Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

被引：0

作者：

Beitzen-Heineke, Antonia ^{[1
,2
,3
]}

Ben Batalla, Isabel ^{[1
,2
,3
]}

Berenbrok, Nikolaus ^{[1
,2
,3
]}

Paesler, Sarina ^{[1
,2
,3
]}

Gensch, Victoria ^{[1
,2
,3
]}

von Amsberg, Gunhild ^{[1
,2
]}

Schafhausen, Philippe ^{[1
,2
]}

Riecken, Kristoffer ^{[4
]}

Fischer, Thomas ^{[5
]}

Pantel, Klaus ^{[3
]}

Bokemeyer, Carsten ^{[1
,2
]}

Loges, Sonja ^{[1
,2
,3
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect BMT, Hamburg, Germany

[2] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect Pneumol, Hamburg, Germany

[3] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Tumor Biol, Hamburg, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Dept Stem Cell Transplantat, Hamburg, Germany

[5] Otto Von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-118175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3063

引用

页数：3

共 50 条

[21] The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium
Griesshammer, Martin
Sadjadian, Parvis
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) : 1929 - 1938
[22] Trisomy 13 in a Philadelphia negative chromosome and BCR-ABL negative myeloproliferative disorder
Cabrol, C
Samii, K
Scherrer, A
Darbellay, R
Beris, P
CANCER GENETICS AND CYTOGENETICS, 1999, 111 (02) : 184 - 185
[23] Outcome of secondary AML following BCR-ABL negative myeloproliferative disorders
Ayari, S.
Chevallier, P.
Guillaume, T.
Garant, R.
Dubruille, V.
Gastinne, T.
Le Gouill, S.
Blin, N.
Mahe, B.
Harousseau, J. L.
Mohty, M.
Moreau, P.
Delaunay, J.
BONE MARROW TRANSPLANTATION, 2009, 43 : S90 - S91
[24] BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms
Koopmans, Suzanne M.
Schouten, Harry C.
van Marion, Arienne M. W.
HISTOLOGY AND HISTOPATHOLOGY, 2015, 30 (02) : 151 - 161
[25] BCR-ABL transcripts in Philadelphia-negative myeloproliferative disorders.
Aviram, A
Blickstein, D
Luboshitz, J
Stark, P
Bairey, O
Prokocimer, M
Magen, H
Shaklai, M
EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 797 - 797
[26] Differential diagnosis of BCR-ABL1-negative myeloproliferative neoplasms
Kvasnicka, Hans Michael
Griesshammer, Martin
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 301 - 310
[27] GENETIC ABNORMALITIES IN DIAGNOSTICS OF BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Kozlovskaya, M.
Martynkevich, I.
Petrova, E.
Martynenko, L.
Ivanova, M.
Cybakova, N.
Gritsaev, S.
Shuvaev, V.
Abdulkadyrov, K.
HAEMATOLOGICA, 2013, 98 : 618 - 618
[28] Approach to Diagnosis of BCR::ABL1 -Negative Myeloproliferative Neoplasms
Satiza, Manali
Purohit, Abhishek H. L.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (06) : 585 - 591
[29] Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms
Falanga, Anna
Marchetti, Marina
Schieppati, Francesca
HAMOSTASEOLOGIE, 2021, 41 (01): : 48 - 57
[30] Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
J-J Kiladjian
C Chomienne
P Fenaux
Leukemia, 2008, 22 : 1990 - 1998

← 1 2 3 4 5 →